title: The expression of HSP60 and HSP10 in large bowel carcinomas with lymph node metastase.
abstract: BACKGROUND
  The involvement of Heat Shock Proteins (HSP) in cancer development and progression is a widely debated topic. The objective of the present study was to evaluate the presence and expression of HSP60 and HSP10 in a series of large bowel carcinomas and locoregional lymph nodes with and without metastases.
  
  
  METHODS
  82 Astler and Coller's stage C2 colorectal cancers, of which 48 well-differentiated and 34 poorly-differentiated, were selected along with 661 lymph nodes, including 372 with metastases and 289 with reactive hyperplasia only, from the same tumours. Primitive tumours and both metastatic and reactive lymph nodes were studied; specifically, three different compartments of the lymph nodes, secondary follicle, paracortex and medullary sinus, were also analysed. An immunohistochemical research for HSP60 and HSP10 was performed and the semiquantitative results were analysed by statistical analysis to determine the correlation between HSPs expression and 1) tumour grading; 2) degree of inflammation; 3) number of lymph nodes involved; 4) lymph node compartment hyperplasia. Moreover, western blotting was performed on a smaller group of samples to confirm the immunohistochemical results.
  
  
  RESULTS
  Our data show that the expression of HSP60, in both primary tumour and lymph node metastasis, is correlated with the tumoral grade, while the HSP10 expression is not. Nevertheless, the levels of HSP10 are commonly higher than the levels of HSP60. In addition, statistical analyses do not show any correlation between the degree of inflammation and the immunopositivity for both HSP60 and HSP10. Moreover, we find a significant correlation between the presence of lymph node metastases and the positivity for both HSP60 and HSP10. In particular, metastatic lymph nodes show a higher percentage of cells positive for both HSP60 and HSP10 in the secondary follicles, and for HSP10 in the medullary sinuses, when compared with hyperplastic lymph nodes.
  
  
  CONCLUSIONS
  HSP60 and HSP10 may have diagnostic and prognostic significance in the management of this tumour and their overexpression in tumoral cells may be functionally related to tumoral progression. We hypothesise that their expression in follicular and medullary cells of lymph nodes may be induced by formation of metastases. Further studies based on these observations could lead to a better understanding of the HSPs involvement in colorectal cancer progression, as well as other neoplasms.
authors.affiliation: Sezione di Anatomia Umana, Dipartimento di Medicina Sperimentale, Università degli Studi di Palermo, Italy. francapp@hotmail.com
authors.forename: Francesco
authors.initials: F
authors.lastname: Cappello
authors.forename: Sabrina
authors.initials: S
authors.lastname: David
authors.forename: Francesca
authors.initials: F
authors.lastname: Rappa
authors.forename: Fabio
authors.initials: F
authors.lastname: Bucchieri
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Marasà
authors.forename: Tommaso E
authors.initials: TE
authors.lastname: Bartolotta
authors.forename: Felicia
authors.initials: F
authors.lastname: Farina
authors.forename: Giovanni
authors.initials: G
authors.lastname: Zummo
mesh_terms: D000704:Analysis of Variance; D014408:Biomarkers, Tumor / Q000378:metabolism; D015153:Blotting, Western; D002277:Carcinoma / Q000378:metabolism* / Q000473:pathology*; D002454:Cell Differentiation; D018835:Chaperonin 10 / Q000096:biosynthesis*; D018834:Chaperonin 60 / Q000096:biosynthesis*; D003106:Colon / Q000473:pathology; D018450:Disease Progression; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D006965:Hyperplasia; D007150:Immunohistochemistry; D007249:Inflammation; D007414:Intestinal Neoplasms / Q000378:metabolism* / Q000473:pathology*; D007420:Intestine, Large / Q000473:pathology*; D008198:Lymph Nodes / Q000473:pathology; D008207:Lymphatic Metastasis; D009362:Neoplasm Metastasis; D013997:Time Factors
chemical_list: D014408:Biomarkers, Tumor; D018835:Chaperonin 10; D018834:Chaperonin 60